Connect with us

Cannabis News

No, Celebrity Brands Don’t Outperform Traditional Cannabis Brands

Published

on


celebrity weed brands

MJ BIZ recently reported that celebrity-endorsed cannabis brands like Houseplant by Seth Rogan and Khalifa Kush by Wiz Khalifa have the undeniable advantage of leveraging their vast fan bases and social media followers to capture consumer attention and generate excitement.

 

Wait a minute, I thought celebrity brands and co-branding by celebrities didn’t move the needle much on cannabis sales?

 

Previous articles on Cannabis.net like “Your Celebrity Branding Doesn’t Mean S#$%#”, or the Bloomberg news piece called “Celebrity Star Power Has So Far Had a Limited Impact on Cannabis Sales” both paint a different picture of the effectiveness of celebrity brands in weed.

 

What is going on then? Do celebrities bring enough juice to a brand to boost sales over time? Every customer survey done of cannabis buyers says that consumers care about three things, price, effect, and distance or time needed to get the product.  Consumers don’t remember logos or colors or brand names, they do remember how much they paid, did the product work as expected, and how long or how much hassle was it to get said product.

 

Let’s dissect the MJ BIZ article to see if the headline matches the data.

 

It didn’t take long to get past the headline and find some “ah-ha” moments. To start:

 

A recent analysis of retail sales data from Headset indicates that these inherent qualities and other factors, such as promotional events and partnerships, significantly drive consumer purchases.

 

The first noticeable “asterisks” to the story, if you will, is that promotional events and partnerships SIGNIFICANLY drive consumer purchases of these brands.  Reading between the lines means if Mike Tyson shows up at a dispensary or venue, his brand sells out that day.  If Justin Bieber shows up to promote his pre-rolls at an event, the pre-rolls sell out that day.  So having the celebrity actually there signing autographs and pushing his or her product is a big sales driver.  Makes sense, but not repeatable on a daily basis with consumers.  This is the Amazon Prime day example, when Amazon runs a 48-hour July special to get a massive consumer spending push.  It pulls revenue from past and future sales for Amazon as consumers wait for Prime Day to buy something, or speed up a future purchase to get the discounts from Prime.  It is a push-pull effect on sales, robbing Peter to pay Paul as they say.

 

Then the smoking gun pops up on consumer preference and celebrity branding. To whit:

 

Interestingly, celebrity brands tend to offer lower price points than their traditional counterparts, with Headset data revealing that they charge less than the average of $23.14 per item set by traditional cannabis brands.

price points of celebrity cannabis brands

Hold the fort. That is data that is congruent to every consumer study and survey done in Canada or the US.  Forget the word celebrity for a second, “brands that offer lower price points…get more sales”. So, are consumers buying celebrity brands or are they buying brands that offer lower price points? Past data says consumers care about price points very much, branding not so much.  So, is this a cause of celebrity causation being confused with correlation?  It is a common misconception in statistics gathering, causation and correlation, did something actually cause an effect or is it just correlated with the results you are looking at. In this case, it sure appears that celebrity branding is a correlation to consumer choosing the lower price point product, not a causation of why someone bought a product.

 

Did someone buy a Ric Flair Drip gummy because it was from Ric Flair or because it was 36% cheaper than the traditional, non-celebrity brand next to it on the shelf?  ($14.91 vs. $23.14) If Ric Flair is at your dispensary that day promoting his product as mentioned above as an “event”, then it is a no-brainer what the 50-person line out the door is going to buy and get autographed that day.  Again, a one-time event is not repeatable over time.  If Ric Flair is not at the dispensary on a regular day, is the consumer buying X brand 10mg gummies for $14.91 or comparable product at $23.14?  Data says the consumer will look at price point and effect first and foremost.

 

The MJ BIZ article reports that during the first three months of 2023, the study compared over 20 celebrity brands to a representative sample of more than 1,300 traditional marijuana brands.

 

So, comparing the top 20 celebrity brands to the entire field of 1,300 marijuana brands is a fair statistical parameter?  Seems like someone is cooking the books to get the results they want from the survey. Why not do the top 20 celebrity brands vs. the top 20 or 40 traditional brands to make it a fair fight, or to get a statically accurate “apples to apples” comparison?  I’ll take Backwoods vs any celebrity brand, let’s compare numbers.  You want to have an educated discussion about branding in the cannabis industry, let’s talk Cookies, not Justin Bieber’s Peaches.

 

There are well known lists of “zombie” brands that have run out of money and don’t do any marketing in California.  Keeping them in the data pool will certainly bring down the numbers of traditional brands and boost the “appeal” number of celebrity brands.

 

Comparing 20 celebrity brands to 1,300 traditional brands isn’t a fair comparison.  Someone should have cut it to at least the top 50 selling traditional, non-celebrity brands, to get an accurate comparison on how much influence a celebrity really has on consumer choices in a dispensary.

 

In the first quarter, celebrity brands in the California market, including Cann, Houseplant, and Mirayo by Santana, outperformed traditional cannabis brands by a significant margin, as reported by Headset, a cannabis analytics provider based in Seattle.

 

 

Headset’s findings indicate that traditional brands achieved an average monthly sales figure of $26,591. However, at least nine celebrity brands surpassed this figure, with five generating monthly revenues well above the $100,000 mark.

 

Again, would love to know the above sales number for just the top 50 traditional brands like Backwoods. What are we guessing that number jumps up to we eliminate 1,000 zombie brands in California?  Well over the $100,000 mark just like the top 10 celebrity brands are doing I would bet.

 

The Celebrity Phenomenon in California’s Marijuana Market

 

Cann, a popular marijuana beverage producer endorsed by Hollywood celebrities, influencers, and professional athletes, has far outperformed traditional cannabis brands by a staggering margin of almost 30-to-1.

 

This one is probably true because Cann is a carbonated infused beverage.  High moats in that area, capital intensive to get started, tough for competitors to ramp up in that area.  Is Cann super successful due to the celebrity part or just because they are “the only game in town” in that niche and well capitalized. Did the execute a successful business plan or get the right celebrity? I am going the latter.

 

Notable investors and brand ambassadors for Cann include actress Gwyneth Paltrow, entertainer and comedian Rebel Wilson, and former NBA player Baron Davis.

 

Mitchell Laferla, a data analyst at Headset, shared via email with MJBizDaily, “From my perspective, several celebrity-affiliated brands have achieved remarkable success compared to typical cannabis brands in California.”

 

Are those several celebrity brands selling at a 36% discount to the market like Ric Flair Drips, as well? If so, that may help explain their “remarkable success”.

 

From a business standpoint, celebrity-endorsed brands have a unique advantage in opening doors and establishing connections with potential partners, enabling them to create distinctive promotions and foster meaningful customer interactions. Drew Punjabi, the brand manager of 22Red, a California cannabis lifestyle brand founded by entrepreneur and System of a Down bassist Shavo Odadjian, emphasized this point.

 

From the consumer perspective, the presence of celebrities in retail stores is highly sought after and plays a crucial role in driving engagement and, ultimately, sales, according to Punjabi. He highlighted the significance of influence in 2023, stating, “Celebrities possess that valuable connection with their fans and followers.”

 

Ahhh, the presence of the actual celebrity in the retail store is a highly sought after thing and plays a crucial role in sales for that celebrity brand.  Well, yeah, if Mike Tyson will be your budtender Monday to Friday, 8 to 5, you are going to sell a lot of Tyson Bites and his brand will sell very well.

 

“In an industry where physical, in-person retail sales remain paramount, having the ability to attract hundreds of people to a dispensary for meet-and-greets or events tied to product promotions or new releases is a massive advantage,” Punjabi added.

 

Beating a dead horse now, game, set, match.

 

A New Approach to Celebrity-Backed Cannabis Brands

 

According to Headset, Los Angeles-based Cann has established itself as the dominant brand in celebrity endorsements, achieving impressive average monthly sales of $751,760 in California during the first quarter.

 

Early in its journey, the company partnered with Imaginary Ventures, a New York-based venture capital firm renowned for its successful contributions to Good American and Skims celebrity apparel brands.

 

Interestingly, Good American was co-founded by Khloé Kardashian, while Kim Kardashian founded Skims.

 

Rather than relying on celebrities already associated with cannabis, such as rapper Snoop Dogg or country music icon Willie Nelson, Cann opted for a different approach.

 

“We believed that if we could secure a mainstream celebrity who isn’t typically associated with cannabis, we could revolutionize the conversation and normalize it in a fresh and impactful manner,” explained Luke Anderson, co-founder of Cann.

 

“We successfully conveyed that cannabis is for everyone, not exclusively for those seeking an intense high.”

 

Ahh, low dose cannabis beverages are very popular and a booming niche, agreed. Celebrity causation or correlation here?

 

Challenges of Sustaining a Celebrity Brand

 

Working with celebrities poses unique challenges beyond the typical obstacles faced by cannabis companies.

 

According to Black, one of the top challenges is overcoming consumer perceptions. These perceptions cover a wide range of factors, including product quality, brand authenticity and celebrity partnership authenticity, retail prices, and celebrity involvement in the company’s operations.

 

Wait, consumers are questioning if celebrities are really involved in a brand or just sold their likeness and image to a brand for a quick buck? No way!

 

For Black, brand stewardship and the “do no harm” principal guide most of his decisions. He aims to preserve the 52-year legacy of Cheech and Chong without making any detrimental missteps.

 

Running a celebrity brand comes with immense pressure, with unexpected incidents, scandals, and the potential threat of “cancel culture” being significant concerns for operators in this space.

 

Last year, Tyson was involved in a physical altercation with an unruly passenger before Tress invested in Tyson 2.0. Despite the incident receiving national attention, Tyson’s image remained largely unscathed, showcasing his enduring popularity.

 

However, despite the pull of celebrities, consumer awareness of celebrity-endorsed brands varies across different markets. According to Madeline Scanlon, cannabis insights manager at Brightfield Group, over 80% of California cannabis consumers are unaware of brands like Cann and Houseplant and their celebrity affiliations. This suggests that factors like product positioning, marketing strategies, and operational efficiency play a more significant role in achieving success, as Scanlon emphasizes.

 

Wowza!  The headline of the article is celebrity brands are killing it because of celebrities! What does Madeline mean that most consumers are unaware of what celebrities promote what brands, but instead look at product placement, pricing, and how easy or hard it is to get the product.  How dare she!  That would be 100% the opposite of the article headline would leave you to believe.

 

Being a celebrity alone is not enough to succeed; a truly successful brand requires additional components beyond celebrity endorsement, Scanlon asserts. A celebrity brand’s relevance often depends on the longevity and continued significance of the celebrity associated with it.

 

You mean no one under the age of 30 knows who Ric Flair or Cheech and Chong are right now? That could be a longevity problem for a brand, too.

 

This challenge is consistently faced by the executives behind Garcia’s Hand Picked, which ranks No. 7 on the list with monthly sales of $80,587 in the first quarter.

 

The brand, a division of the vertically integrated company Holistic Industries, pays tribute to Jerry Garcia, the iconic frontman of the Grateful Dead and a symbol of counterculture. Garcia passed away from a heart attack in 1995.

 

Winning over Deadheads, a famously opinionated and anti-corporate community, is impossible. They demand high-quality cannabis flowers, unique strains, and a constant flow of new products, known as SKUs (stock-keeping units), according to Kyle Barich, the chief marketing officer at Holistic, based in Maryland.

 

“Much of my professional life involves catering to this challenging audience,” Barich noted.

 

Recently, the brand wrapped up significant sponsorship at The Peach Music Festival in Scranton, Pennsylvania, where its logo was prominently displayed on signage and on one of the main stages. This marked a significant milestone for the company as it crossed into mainstream music events.

 

Ahhh, one time music festival push, got it.

 

Holistic takes responsibility seriously in the Grateful Dead realm and collaborates closely with the Garcia family trust and foundation on matters such as SKUs, merchandise, branding, marketing, and other business decisions.

 

“We are incredibly privileged to have the opportunity to honor the legacy of Jerry Garcia, whom we all deeply admire,” Barich expressed enthusiastically.

 

Bottom Line

 

The headline highlights the significant impact of celebrity endorsements in the cannabis industry. By reading through the article the reality of the data supports what we already know and what consumers are saying in surveys. Celebrity brands have demonstrated their ability to attract consumer attention, drive sales at events the celebrity is at, and outperform traditional brands when every traditional brand is put in the data set, but is not a true comparison when you compare the top 20 celebrity brands to 1,300 non-celebrity brands. Leveraging the influence of celebrities, some brands have successfully navigated challenges, including consumer perceptions and market awareness. However, it is crucial to recognize that celebrity endorsement alone does not guarantee success, in fact, just the opposite. Additional factors such as product positioning, pricing, marketing strategies, and operational efficiency also play a vital role in achieving sustained growth and brand recognition. Celebrity brands must adapt and maintain relevance as the industry continues to evolve to ensure long-term success in this competitive landscape.

 

THE MYTH OF CELEBRITY BRANDING IN CANNABIS, READ ON…

CELEBRITY BRANDS IN MARIJUANA

YOUR CELEBRITY BRAND DOESN’T MEAN S#$% TO CONSUMERS!



Source link

Cannabis News

Turns Out the ‘Barstool of Weed’ Isn’t Cannabis.Net After All, But It’s Actually Barstool Sports Itself!

Published

on

By


barstool marijuana cannabis industry

Barstool Sports Expands Into Cannabis Industry, Partners With Green Thumb Industries

Cannabis.net, often referred to as the “Barstool of Weed” since 2016, will happily relinquish that crown as Barstool Sports itself has jumped into the cannabis game with GTI!

In a groundbreaking move that highlights the growing intersection between sports media and the cannabis industry, Barstool Sports has announced a strategic partnership with Green Thumb Industries (GTI), one of the leading multi-state cannabis operators in the United States. This collaboration aims to elevate GTI’s cannabis brands, particularly RHYTHM and Dogwalkers Prerolls, through innovative content and marketing strategies that resonate with Barstool’s extensive audience. As cannabis continues to gain acceptance and legalization spreads across various states, this partnership marks a significant step for both companies in navigating the evolving landscape of cannabis culture.

“Being a fellow Masshole, I couldn’t be happier for Dave and his crew.” said Curt Dalton, managing director of Cannabis.net. “He has been at the cutting edge of partnerships in the legalization of online gambling, as well as now cannabis.” added Dalton.

 

The Rise of Barstool Sports

 

Founded in 2003 by Dave Portnoy, Barstool Sports has transformed from a small sports blog into a media powerhouse with a diverse portfolio of content spanning podcasts, video series, and social media platforms. With over 66 million monthly unique viewers, Barstool has established itself as a leading voice in sports entertainment, particularly among younger demographics. The brand is known for its irreverent humor, candid commentary, and engaging personalities, which have cultivated a loyal fanbase.

 

Barstool’s expansion into new markets has been a hallmark of its growth strategy. The company has successfully ventured into various sectors, including gambling and merchandise sales. By entering the cannabis industry, Barstool aims to capitalize on the burgeoning market while further solidifying its position as a cultural influencer.

 

Understanding Green Thumb Industries

 

Green Thumb Industries is a publicly traded company based in Chicago that operates across several states in the U.S., focusing on cultivating, manufacturing, and distributing cannabis products. GTI is known for its commitment to quality and innovation in the cannabis space, offering a wide range of products that cater to different consumer preferences. Their brands include RHYTHM, which focuses on high-quality flower and concentrates, and Dogwalkers Prerolls, designed for convenience and portability.

 

GTI’s approach to cannabis is rooted in social responsibility and community engagement. The company prioritizes sustainability and ethical practices throughout its operations while advocating for responsible consumption. This alignment of values makes GTI an ideal partner for Barstool Sports as both companies seek to normalize cannabis use and promote responsible consumption among their audiences.

 

 The Partnership: What It Means for Both Brands

 

The partnership between Barstool Sports and Green Thumb Industries is set to create a unique synergy that leverages Barstool’s extensive reach within the sports community while providing GTI with innovative marketing opportunities. Here are some key aspects of what this collaboration entails:

 

1. Content Creation

 

One of the primary focuses of this partnership will be on content creation that seamlessly integrates GTI’s products into Barstool’s existing media channels. This could include sponsored segments on popular podcasts like “Pardon My Take,” video content featuring Barstool personalities using or discussing GTI products, and social media campaigns designed to engage followers.

 

The goal is to present cannabis in a relatable and entertaining manner while educating consumers about responsible use. By utilizing Barstool’s humor-driven approach, the partnership aims to destigmatize cannabis consumption and encourage open discussions about its benefits.

 

 2. Brand Visibility

 

With millions of followers across various platforms, Barstool Sports provides an unparalleled opportunity for GTI to enhance its brand visibility. The partnership will allow GTI to reach new audiences who may not be familiar with their products or the cannabis industry as a whole.

 

Through targeted marketing campaigns and engaging content, GTI can effectively communicate its brand message while showcasing the quality and variety of its offerings. This increased visibility can lead to higher consumer interest and ultimately drive sales.

 

3. Navigating Regulatory Challenges

 

The cannabis industry faces numerous regulatory challenges when it comes to advertising and marketing. Many traditional advertising platforms impose strict limitations on how cannabis brands can promote their products. However, by partnering with Barstool Sports, a platform known for its innovative approach to content—GTI can navigate these challenges more effectively.

 

Barstool’s established reputation allows it to create engaging content that adheres to legal guidelines while still resonating with audiences. This partnership could serve as a model for other brands looking to enter the cannabis space without running afoul of advertising regulations.

 

 

4. Normalizing Cannabis Culture

 

As societal attitudes toward cannabis continue to evolve, there is an increasing need to normalize cannabis culture within mainstream media. Both Barstool Sports and GTI share a vision of promoting responsible cannabis consumption while breaking down stereotypes associated with its use.

 

Through entertaining content that highlights the benefits of cannabis whether for relaxation or social enjoyment, the partnership aims to foster acceptance among audiences who may have previously held reservations about cannabis use. By integrating these messages into popular sports culture, both companies hope to reshape perceptions around cannabis consumption.

 

 Cannabis Legalization in America

 

The partnership between Barstool Sports and Green Thumb Industries comes at a time when the landscape of cannabis legalization in the United States is rapidly changing. Over the past decade, numerous states have legalized cannabis for medical or recreational use, leading to an explosion of growth within the industry.

According to recent reports from industry analysts, the legal cannabis market in the U.S. is projected to exceed $41 billion by 2025. As more states consider legalization measures and public opinion shifts toward acceptance, businesses within this sector are poised for significant growth opportunities.

 

 

The economic impact of legalized cannabis extends beyond just sales revenue; it also creates jobs and generates tax revenue for state governments. States that have embraced legalization have seen substantial increases in tax collections from cannabis sales—funds that can be allocated toward education, healthcare, infrastructure projects, and more.

 

As major players like Barstool Sports enter this space through partnerships with established companies like GTI, they contribute not only to their own growth but also help shape an industry that has far-reaching implications for local economies across the country.

 

 

The cultural shift surrounding cannabis cannot be understated either; it reflects broader changes in societal attitudes toward substance use overall. As more people advocate for legalization based on health benefits or personal freedom arguments rather than stigma or fear-based narratives—companies like Barstool Sports are well-positioned to influence these conversations positively.

 

By engaging audiences through humor-infused storytelling around cannabis culture—whether discussing strains suited for game day or highlighting responsible consumption practices. Barstool can play an essential role in shaping how future generations view this plant-based product.

 

Future Opportunities

 

As this partnership unfolds over time there are numerous opportunities available not only within marketing but also product development itself! Some potential avenues include:

 

 1. Co-Branded Products

 

Given both brands’ strong identities there may be potential for co-branded products tailored specifically toward Barstool fans. Imagine limited edition pre-rolls branded with iconic catchphrases from popular podcasts or even themed merchandise that combines sports memorabilia with cannabis culture.

 

2. Events & Activations

 

Another exciting possibility lies within live events or activations where fans can engage directly with both brands! Whether through tailgates at sporting events featuring product sampling or hosting exclusive meet-and-greets these experiences could deepen connections between consumers while promoting responsible usage!

 

3. Educational Initiatives

 

Lastly education remains crucial when it comes to destigmatizing marijuana use! Collaboratively creating informative content focused on health benefits associated with different strains could empower consumers while reinforcing positive messages around safe consumption practices!

 

 Conclusion

The partnership between Barstool Sports and Green Thumb Industries represents not just an exciting development within two distinct industries but also signals broader changes occurring across American society regarding perceptions around marijuana usage!

 

By leveraging each other’s strengths Barstool’s vast audience reach combined with GTI’s expertise in quality product offerings, this collaboration sets out not only to entertain but also educate consumers about responsible consumption habits while normalizing discussions surrounding marijuana use!

 

As we look ahead, it will be fascinating to see how this partnership evolves over time; paving new pathways not only for both brands but potentially reshaping cultural narratives surrounding one of America’s most controversial yet rapidly growing industries!

 

ODE TO BARSTOOL, READ ON…

MORALITY OF WEED COMPARED TO GAY PORN AND FUR

THE MORALITY OF WEED COMPARED TO GAY PORN OR WEARING FUR!



Source link

Continue Reading

Cannabis News

How Social Media is Driving Change

Published

on

By


cyprus marijuana legalization

In recent days, the conversation around cannabis legalization in Cyprus has reached a new level of intensity. About eight days ago, social media platforms like Twitter (now X), Facebook, and Instagram began buzzing with discussions, petitions, and activist campaigns advocating for broader access to medical cannabis and the legalization of personal cultivation. This surge of public interest and online activism comes after years of stagnation in the country’s cannabis policy implementation, despite medical cannabis being legalized as far back as 2017.

The Social Media Movement: A Force to Be Reckoned With

The current social media push began as a coordinated effort from various grassroots organizations and activists who were frustrated with the government’s slow progress in making medical cannabis available to patients who need it most. What began as a few isolated posts has now transformed into a powerful movement that shows no signs of slowing down.

Over the last eight days, platforms like Facebook, X, and Instagram have been flooded with posts, hashtags, and even paid advertisements advocating for the swift implementation of the medical cannabis law. The message is clear: Cypriots want immediate access to cannabis for therapeutic purposes and the right to grow their own plants for personal use.

Petitions supporting these changes are circulating widely, and the number of signatures is rapidly growing. Just this past week, one campaign calling for the legalization of medical cannabis and personal cultivation surpassed 1,000 signatures. The petition’s momentum is showing no signs of slowing down, with organizers now setting their sights on reaching 1,500 signatures and beyond. Once the campaign hits 2,000 signatures, organizers plan to submit their petition to the Ministry of Health, urging officials to take concrete steps towards implementation and reform.

The Broader Cannabis Landscape in Cyprus

To understand the current movement, it’s important to take a step back and look at the broader cannabis landscape in Cyprus. In 2017, Cyprus took its first steps towards legalizing medical cannabis, allowing it to be prescribed to patients suffering from serious conditions such as cancer. In 2019, the government expanded the scope of the law, extending access to patients suffering from chronic pain, multiple sclerosis, epilepsy, and glaucoma. This legislative change brought hope to thousands of Cypriots suffering from chronic conditions.

However, despite the legal framework being in place, patients are still struggling to access medical cannabis due to bureaucratic and regulatory delays. As of today, there are still no significant efforts to issue the licenses necessary to start cultivation and distribution. This lack of action has left many patients without access to the treatment they desperately need, driving activists to take their message to social media.

Why Now? What’s Driving the Surge?

The recent social media buzz didn’t happen in a vacuum. Several factors have contributed to the sudden increase in online activity around cannabis legalization in Cyprus.

  1. Frustration with Government Delays: Patients who qualify for medical cannabis under the law have found that they cannot access it. While medical cannabis is technically legal, the lack of implementation means that those who need it are often left to seek alternatives in the black market, which is both risky and illegal.

  2. Global Momentum: Across Europe and the world, cannabis legalization is advancing. Countries like Malta, Germany, Luxembourg, and Spain have implemented more progressive cannabis laws, including personal cultivation models, which allow individuals to grow a small number of plants for personal use. Meanwhile, Canada, certain states in the U.S., and even Thailand have made significant strides in cannabis regulation. Cypriots are watching these developments unfold and are pushing their government to follow suit.

  3. Public Health and Economic Arguments: Advocates argue that legalizing personal cannabis cultivation not only provides critical relief for patients but also presents an economic opportunity for Cyprus. Legalizing cannabis cultivation could create new jobs and generate tax revenue, which could be reinvested in healthcare and education. Furthermore, regulation would help cut down on the black market, ensuring that consumers have access to safe, tested products.

  4. The Power of Social Media: Social media platforms have proven to be incredibly effective tools for organizing and rallying support. By using hashtags, paid ads, and viral content, activists are reaching a wide audience quickly and efficiently. In just a matter of days, thousands of Cypriots have joined the conversation, sharing posts and signing petitions to advocate for change.

The Role of Media and Influencers

As the movement continues to grow, traditional media outlets are starting to take notice. Cyprus Mail, and other media platforms have been covering the ongoing discussions about medical cannabis and the delays in implementing the law. These news outlets are amplifying the social media buzz, giving the movement additional visibility and legitimacy.

Moreover, key influencers in the Cypriot cannabis community have stepped up to the plate. Organizations like CY-CA.org (Cyprus Cannabis Association) have been particularly vocal about the need for reform. Recently, Andria Andreou, President of CY-CA, expressed her support for the movement, proposing collaboration between activists and organizations to present a unified front to the government. This growing partnership between grassroots activists and more established organizations like CY-CA is helping the movement gain credibility and momentum.

What Happens Next?

With the petition quickly gaining signatures, the next step for activists is to continue applying pressure on both the Ministry of Health and the media. The goal is to keep the conversation going, ensuring that the issue remains front and center in public discourse.

As the campaign approaches 1,500 signatures, activists plan to strengthen their collaboration with organizations like CY-CA to amplify their message and gain further support. Once the petition reaches 2,000 signatures, the plan is to formally submit the request to the Ministry of Health, calling for the immediate distribution of medical cannabis in pharmacies, as well as the adoption of personal cultivation models similar to those in countries like Malta and Germany.

Additionally, activists are preparing to push for a public consultation on cannabis reform, allowing citizens to voice their opinions and concerns. This would be a major step forward, potentially paving the way for more comprehensive cannabis legislation that covers both medical and recreational use.

Why Personal Cultivation Matters

One of the most pressing demands of the movement is the legalization of personal cannabis cultivation. This model, which allows individuals to grow a small number of cannabis plants for personal use, has been successfully implemented in several European countries. Advocates argue that allowing personal cultivation would give patients more control over their treatment, ensuring that they have access to high-quality cannabis without having to rely on the black market.

Moreover, personal cultivation could help address the supply shortages that are likely to occur if and when the government begins to issue cultivation licenses. By allowing individuals to grow their own plants, the government can help ensure that patients have immediate access to the treatment they need while the industry develops.

The Role of the Health Minister: What Will He Do?

As the pressure mounts, all eyes are now on Health Minister Michalis Damianos, who has publicly stated his commitment to improving healthcare services. Recently, the Minister reiterated that “health is the ultimate good” and that his work focuses on ensuring patients’ rights. Given his statements, the question now is: Will he act on medical cannabis reform?

With over 1,000 signatures supporting cannabis legalization, the Minister faces increasing public pressure. His previous efforts to modernize health services and legislative frameworks suggest that the full implementation of medical cannabis laws could be the next logical step. Will he take the necessary steps to ensure that patients gain safe and legal access to cannabis?

The Final Push: Why Your Voice Matters

As the movement for cannabis reform in Cyprus gains traction, it’s more important than ever for citizens to get involved. Whether it’s signing the petition, sharing posts on social media, or reaching out to local representatives, every action counts. The more support the movement gains, the harder it will be for the government to ignore the growing demand for change.

In the coming weeks, the conversation around cannabis legalization in Cyprus is likely to intensify. With continued pressure from both social media and the media, there’s a real chance that the government will finally take action to implement the laws that have been on the books since 2017.

For now, the activists and advocates behind the movement are calling on all Cypriots to join the conversation and make their voices heard. The future of cannabis legalization in Cyprus is being written right now—and with enough public support, change could be just around the corner.

 

CYPRUS’ GROWING MARIJUANA VOICE, READ ON…

CYPRUS MEDICAL MARIJUANA BILL

CYPRUS HAS BEEN PUSHING FOR MEDICAL MARIJUANA FOR 6 YEARS!



Source link

Continue Reading

Cannabis News

The Guy Who Made Marijuana Illegal in 1971 Said Weed Really Isn’t That Bad on Secret Tape Recordings

Published

on

By


Nixon on marijuana not being that bad

Secret Tapes Reveal that the Father of the Drug War didn’t think that weed was that bad

Richard Nixon, often regarded as the “Father of the Drug War,” left an indelible mark on American drug policy that continues to shape our society today. In 1971, Nixon signed the Controlled Substances Act (CSA) into law, setting in motion a series of events that would dramatically alter the landscape of drug regulation and enforcement in the United States. This pivotal piece of legislation not only granted pharmaceutical companies a virtual monopoly over drug production and distribution but also weaponized the justice system against non-violent individuals who chose to consume substances deemed illegal by the government.

Nixon’s public stance on drugs, particularly marijuana, was uncompromising and harsh. He championed a zero-tolerance approach, famously declaring drug abuse as “public enemy number one” and calling for an “all-out offensive” against it. This rhetoric laid the groundwork for decades of aggressive anti-drug policies that have led to the incarceration of countless individuals for non-violent drug offenses.

However, recently uncovered secret recordings paint a starkly different picture of Nixon’s private views on marijuana. These tapes, captured in the intimate chambers of his staff meetings, reveal a man whose personal opinions on cannabis were far more nuanced and less severe than his public pronouncements suggested. The disconnect between Nixon’s public policy and private thoughts raises troubling questions about the foundations of the War on Drugs and its lasting impact on American society.

Today, we’ll take a deep dive into Nixon’s recorded statements, analyzing them in the context of a nation where hundreds of thousands of people continue to face legal consequences for cannabis-related offenses. As we examine these private conversations, we’ll confront the unsettling reality that the architect of America’s drug war may have been fully aware of the disconnect between marijuana’s actual risks and the draconian measures he publicly supported to combat its use.

The public persona of Richard Nixon was that of a staunch anti-drug crusader, a man who viewed drug abuse as an existential threat to American society. In June 1971, Nixon famously declared drug abuse as “public enemy number one” and called for a “new, all-out offensive” to combat it. This declaration effectively launched the War on Drugs, a campaign that would reshape American criminal justice policy for decades to come.

Nixon’s public actions matched his rhetoric. He signed the Controlled Substances Act in 1970, which established the scheduling system for drugs that remains in place today. Under this system, marijuana was classified as a Schedule I substance, alongside drugs like heroin, deemed to have “no currently accepted medical use and a high potential for abuse.” This classification flew in the face of scientific evidence even then, but it aligned with Nixon’s public stance on cannabis.

The case of Timothy Leary, the LSD researcher and counterculture icon, exemplifies Nixon’s public approach to drug enforcement. In March 1970, Leary received a draconian sentence of up to 10 years in prison for possessing less than an ounce of marijuana. Rather than viewing this as an excessive punishment, Nixon doubled down. As he told his Chief of Staff H.R. Haldeman in May 1970, “I want a goddamn strong statement on marijuana. By God we are going to hit the marijuana thing, and I want to hit it right square in the puss.”

Nixon’s public rhetoric often took on racist overtones, particularly when discussing drug use among minority communities. He frequently associated drug use with African Americans and other minorities, using coded language to appeal to white voters’ fears and prejudices. This racialized approach to drug policy was later confirmed by Nixon’s domestic policy chief, John Ehrlichman, who admitted in a 1994 interview that the War on Drugs was designed to target “the antiwar left and black people.”

However, behind closed doors, a different Nixon emerged. Recently uncovered audio recordings reveal a man who privately held much more nuanced views on marijuana. In a March 1973 recording, Nixon candidly admitted, “I know nothing about marijuana. I know that it’s not particularly dangerous; I know most of the kids are for legalizing it.”

This private acknowledgment stands in stark contrast to his public actions and statements. Nixon even expressed misgivings about harsh marijuana penalties, telling John Ehrlichman, “The penalties are ridiculous. I have no problem with the fact that there should be, there should be an evaluation of penalties on it, and there should not be penalties that, you know, like in Texas where people get 10 years for marijuana. That’s wrong.”

In another recording from September 1972, Nixon admitted to being in favor of “modification of penalties in many areas” related to drug offenses, but noted that he didn’t “talk about it anymore.” This suggests a calculated political decision to maintain a tough public stance on drugs, even while privately harboring doubts about the wisdom of such policies.

The disconnect between Nixon’s public and private personas on drug policy is striking and deeply troubling. While publicly championing a war that would lead to the arrest and incarceration of millions of Americans, particularly from minority communities, Nixon privately acknowledged the relative safety of marijuana and the excessive nature of drug penalties. This dichotomy raises serious questions about the true motivations behind the War on Drugs and the lasting impact of Nixon’s public policies on American society.

The ramifications of Nixon’s Controlled Substances Act (CSA) continue to reverberate through American society, more than half a century after its inception. This legislation has fundamentally altered the fabric of the United States, creating criminals out of otherwise law-abiding citizens for non-violent offenses. Perhaps even more insidiously, it has provided law enforcement with broad powers to seize assets from individuals suspected of drug crimes, often without due process or even a conviction.

One of the most troubling aspects of this policy is civil asset forfeiture, which allows law enforcement to confiscate property they believe is connected to criminal activity. This practice has led to numerous abuses, with innocent people having their possessions seized simply because of proximity to alleged drug activity. A stark example of this overreach occurred recently when a Sheriff’s department seized cash trucks from legal cannabis dispensaries. While the company eventually recovered their funds, this incident highlights the ongoing tension between state-level cannabis legalization and federal prohibition.

The human cost of these policies is staggering. Tens of thousands of individuals remain incarcerated for cannabis-related offenses, their lives derailed by laws rooted in Nixon’s public stance on drugs. These are not just statistics; they represent shattered families, lost opportunities, and communities disproportionately impacted by the War on Drugs.

So why should we care about the disparity between Nixon’s private beliefs and public actions? This disconnect exposes the fundamental hypocrisy underpinning the entire War on Drugs. If even the architect of these policies privately acknowledged that marijuana was “not particularly dangerous” and that the penalties were “ridiculous,” it calls into question the entire rationale behind cannabis prohibition.

Nixon’s private admission that he favored “modification of penalties in many areas” related to drug offenses, while publicly championing harsh measures, is particularly damning. It suggests that the severe approach to drug policy was not based on a genuine belief in its necessity or efficacy, but rather on political expediency. This revelation should prompt us to critically re-examine the foundations of our current drug policies.

If the “Father of Prohibition” himself didn’t believe we should be so harsh in our punishments, it’s high time we rethink our entire strategy. The disconnect between Nixon’s private views and public policies underscores the need for a fact-based, compassionate approach to drug policy that prioritizes public health over punitive measures.

Moreover, this discrepancy between private beliefs and public actions is deeply troubling in a leader of a nation. It erodes public trust and undermines the integrity of our democratic institutions. We cannot afford to have leaders who advocate one thing publicly while holding contradictory views privately, especially on issues that have such profound impacts on citizens’ lives and liberties.

The revelations about Nixon’s private views on cannabis should serve as a catalyst for change. They provide compelling evidence that our current approach to drug policy is not just ineffective, but was built on a foundation of political manipulation rather than genuine concern for public welfare. As we grapple with the ongoing consequences of the War on Drugs, including mass incarceration, racial disparities in enforcement, and the erosion of civil liberties, we must use this knowledge to push for meaningful reform.

It’s time to align our drug policies with scientific evidence and principles of justice, rather than political expediency. The hypocrisy revealed in Nixon’s private statements should embolden us to challenge the status quo and work towards a more rational, humane approach to drug policy – one that doesn’t criminalize personal choices and destroy lives over a substance that even the architect of prohibition privately admitted was “not particularly dangerous.”

 

NIXON ON CONTROLLED SUBSTANCES, READ ON…

END THE CONROLLED SUBSTANCE ACT

IS IT TIME TO END THE CONTROLLED SUBSTANCE ACT?



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media